Anti-IL17A Halts the Onset of Diabetic Retinopathy in Type I and II Diabetic Mice

There are ~463 million diabetics worldwide, and more than half have diabetic retinopathy. Yet, treatments are still lacking for non-proliferative diabetic retinopathy. We and others previously provided evidence that Interleukin-17A (IL-17A) plays a pivotal role in non-proliferative diabetic retinopa...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Amy Y., Taylor, Brooklyn E., Barber, Katherine G., Lee, Chieh A., Taylor, Zakary R. R., Howell, Scott J., Taylor, Patricia R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860974/
https://www.ncbi.nlm.nih.gov/pubmed/36674854
http://dx.doi.org/10.3390/ijms24021347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860974/
https://www.ncbi.nlm.nih.gov/pubmed/36674854
http://dx.doi.org/10.3390/ijms24021347

Ejemplares similares